BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19404719)

  • 1. Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.
    Vogiatzi K; Apostolakis S; Voudris V; Thomopoulou S; Kochiadakis GE; Spandidos DA
    J Thromb Thrombolysis; 2010 Jan; 29(1):134-40. PubMed ID: 19404719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
    Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
    Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between 1019C/T polymorphism of Connexin 37 gene and restenosis after coronary stenting].
    Yang Y; Guo SX; Yang ZY; Zhang T; Cao HM; Wang RX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):456-60. PubMed ID: 23926016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
    Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
    Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of interleukin 18, interleukin 10, and matrix metalloproteinase-9 and -137G/C polymorphism of interleukin 18 are associated with incidence of in-stent restenosis after percutaneous coronary intervention.
    Liu W; Liu Y; Jiang H; Ding X; Zhu R; Li B; Zhao Y
    Inflammation; 2013 Oct; 36(5):1129-35. PubMed ID: 23636637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective.
    Vogiatzi K; Apostolakis S; Voudris V; Thomopoulou S; Kochiadakis GE; Spandidos DA
    J Clin Immunol; 2008 Jul; 28(4):329-35. PubMed ID: 18385984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.
    Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of interleukin-10 gene polymorphism with restenosis after percutaneous coronary intervention in Chinese].
    Gao J; Cui RZ; Liu Y; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM; Liu T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):42-6. PubMed ID: 21287508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.
    Osadnik T; Strzelczyk JK; Fronczek M; Bujak K; Reguła R; Gonera M; Gawlita M; Kurek A; Wasilewski J; Lekston A; Gierlotka M; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
    Adv Med Sci; 2016 Sep; 61(2):276-281. PubMed ID: 27162064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.
    Fragoso JM; Zuñiga-Ramos J; Arellano-González M; Alvarez-León E; Villegas-Torres BE; Cruz-Lagunas A; Delgadillo-Rodriguez H; Peña-Duque MA; Martínez-Ríos MA; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):13-7. PubMed ID: 25449332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention.
    Lv L; Ye W; Song P; Chen Y; Yang J; Zhang C; Chen X; Luo F
    BMC Cardiovasc Disord; 2019 Jul; 19(1):176. PubMed ID: 31345174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphism of adiponectin in restenosis after coronary stenting.
    Li HC; Cao GQ; Liu CZ; Tang MM; Zhang XQ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):287-293. PubMed ID: 31389602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent.
    Osadnik T; Strzelczyk JK; Reguła R; Bujak K; Fronczek M; Gonera M; Gawlita M; Wasilewski J; Lekston A; Kurek A; Gierlotka M; Trzeciak P; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
    PLoS One; 2016; 11(3):e0150500. PubMed ID: 26930482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease.
    Azova M; Timizheva K; Ait Aissa A; Blagonravov M; Gigani O; Aghajanyan A; Tskhovrebova L
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34065198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.